Defendant Name:
Aeon Global Health Corp.
Defendant Type:
Public Company
SIC Code:
7372
CUSIP:
05266630
Document Reference:
34-90003
Document Details
Legal Case Name
In the Matter of Aeon Global Health Corp.
Document Name
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
Document Date
25-Sep-2020
Document Format
Administrative Proceeding
AAER
4171
Allegation Type
Issuer Reporting and Disclosure
Document Summary
On September 25, 2020, the SEC instituted settled cease-and-desist proceedings against Aeon Global Health Corp. The Commission stated: "This proceeding involves violations of the federal securities laws in connection with the Respondent’s reporting, books and records, and internal accounting control failures, as well as its failure to maintain Internal Control over Financial Reporting (“ICFR”). Respondent failed to maintain, and did not remediate material weaknesses in, ICFR for fourteen consecutive reporting periods from the period ended March 31, 2016 through the period ended June 30, 2019. In addition, Respondent announced three financial statement restatements during the period from 2016 to 2019."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Compliance Related Independent Consultant
